Literature DB >> 8256110

T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies.

Q Yi1, S Bergenbrant, A Osterborg, E Osby, R Ostman, M Björkholm, G Holm, A K Lefvert.   

Abstract

The stimulation of peripheral blood mononuclear cells by purified autologous and/or allogeneic monoclonal IgG was studied in five patients with multiple myeloma (MM), nine patients with monoclonal gammopathy of undetermined significance (MGUS) and six healthy individuals. Single cells secreting IFN-gamma or IL-2 were identified using an enzyme-linked immunospot assay. Patients' cells were preferentially stimulated by autologous monoclonal IgG at low concentrations (1-100 pg/ml), while 100 ng/ml or higher stimulated T cells both from patients and, to a lesser degree, healthy individuals. This biphasic dose-response of T-cell stimulation by autologous monoclonal IgG was reproduced in all patients. The numbers of cells secreting IFN-gamma and IL-2 in response to allogeneic IgG were significantly lower than the numbers obtained using autologous IgG in patients with MM and MGUS. Cells from healthy individuals were stimulated by allogeneic monoclonal IgG, but to a lesser extent. The results of this study support the presence of idiotype-reactive T cells in patients with MM and MGUS and also may suggest a general but less pronounced T-cell reactivity to monoclonal IgG among these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256110     DOI: 10.1111/j.1365-3083.1993.tb03236.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  13 in total

1.  In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.

Authors:  Hyun Ju Lee; Cheol Yi Hong; Mi Hyun Kim; Youn Kyung Lee; Thanh Nhan Nguyen-Pham; Byoung Chul Park; Deok Hwan Yang; Ik Joo Chung; Hyeoung Joon Kim; Je Jung Lee
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

Review 2.  Immunotherapy strategies for multiple myeloma: the present and the future.

Authors:  Frederick L Locke; Taiga Nishihori; Melissa Alsina; Mohamed A Kharfan-Dabaja
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

3.  Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.

Authors:  Qing Yi; Susann Szmania; John Freeman; Jianfei Qian; Nancy A Rosen; Sanjaya Viswamitra; Michele Cottler-Fox; Bart Barlogie; Guido Tricot; Frits van Rhee
Journal:  Br J Haematol       Date:  2010-07-07       Impact factor: 6.998

Review 4.  Idiotype-specific T cells in multiple myeloma: targets for an immunotherapeutic intervention?

Authors:  Q Yi; A Osterborg
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

5.  Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer.

Authors:  Hyun Ju Lee; Cheol Yi Hong; Chun-Ji Jin; Mi-Hyun Kim; Youn-Kyung Lee; Thanh-Nhan Nguyen-Pham; Hyunah Lee; Byoung Chul Park; Ik-Joo Chung; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Cell Mol Immunol       Date:  2012-01-09       Impact factor: 11.530

Review 6.  Novel immunotherapies.

Authors:  Qing Yi
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

7.  Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.

Authors:  M Wang; L Sun; J Qian; X Han; L Zhang; P Lin; Z Cai; Q Yi
Journal:  Leukemia       Date:  2009-02-19       Impact factor: 11.528

8.  Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth.

Authors:  Sungyoul Hong; Jianfei Qian; Jing Yang; Haiyan Li; Larry W Kwak; Qing Yi
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

9.  Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.

Authors:  Jianfei Qian; Jin Xie; Sungyoul Hong; Jing Yang; Liang Zhang; Xiaohong Han; Michael Wang; Fenghuang Zhan; John D Shaughnessy; Joshua Epstein; Larry W Kwak; Qing Yi
Journal:  Blood       Date:  2007-05-21       Impact factor: 22.113

Review 10.  Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

Authors:  Ivetta Danylesko; Katia Beider; Avichai Shimoni; Arnon Nagler
Journal:  Clin Dev Immunol       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.